Sipuleucel-T functions as a DC vaccine using a recombinant of the prostate tumor-associated antigen prostatic acid phosphatase (PAP) and granulocyte-macrophage colony-stimulating factor (GM-CSF). This evidence concerns the gene ACP3 and neoplasm.